In Washington’s life sciences sector, a streak of companies going public
Washington’s life science industry is thriving. In 2021 so far, almost 50 biotech companies have gone public across the U.S., with several headquartered in the PNW.
This year alone, Sana Technology, Impel NeuroPharma, Nautilus Biotechnology, Absci, Icosavax have all successfully gone public this year. Eliem Therapeutics is pending an IPO.
(Photo courtesy Sans Biotechnology)